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Abstract
Background: Chemical-genetic profiling of inhibitory compounds can lead to identification of their modes of
action. These profiles can help elucidate the complex interactions between small bioactive compounds and the
cell machinery, and explain putative gene function(s).
Results: Colony size reduction was used to investigate the chemical-genetic profile of cycloheximide, 3-amino-
1,2,4-triazole, paromomycin, streptomycin and neomycin in the yeast Saccharomyces cerevisiae. These compounds
target the process of protein biosynthesis. More than 70,000 strains were analyzed from the array of gene deletion
mutant yeast strains. As expected, the overall profiles of the tested compounds were similar, with deletions for
genes involved in protein biosynthesis being the major category followed by metabolism. This implies that novel
genes involved in protein biosynthesis could be identified from these profiles. Further investigations were carried
out to assess the activity of three profiled genes in the process of protein biosynthesis using relative fitness of
double mutants and other genetic assays.
Conclusion: Chemical-genetic profiles provide insight into the molecular mechanism(s) of the examined
compounds by elucidating their potential primary and secondary cellular target sites. Our follow-up investigations
into the activity of three profiled genes in the process of protein biosynthesis provided further evidence
concerning the usefulness of chemical-genetic analyses for annotating gene functions. We termed these genes
TAE2, TAE3 and TAE4 for translation associated elements 2-4.
Background
Predicting gene function is a major goal of systems
molecular biology in the post genome sequencing era.
In this context, the yeast Saccharomyces cerevisiae has
emerged as the eukaryotic model organism of choice for
large-scale functional genomic investigations. Yeast cells
have been subjected to a number of high throughput
investigations such as gene expression analysis [1], pro-
tein-protein interaction mapping [2,3] and synthetic
genetic interaction analysis [4]. Much knowledge relat-
ing to the functions of yeast genes has been collated but
a significant number of genes are still not characterized
in this model organism [5]. Consequently, further stu-
dies are required to examine the function(s) of unchar-
acterized genes, and to investigate novel function(s) for
genes that are not fully characterized.
Increased sensitivity of gene deletion mutant strains to
inhibitory compounds has been used extensively to
study gene functions [6,7]. This approach is partly based
on the theory that in general, the presence of redundant
pathways compensates for genetic inactivation of a sin-
gle pathway, with no phenotypic consequence [8]. How-
ever, the inactivity of a second functionally overlapping
pathway, in this case using a chemical treatment, can
cause a “double hit” effect and result in a phenotypic
consequence that can be scored as a reduction in the
rate of growth, or a sick/sensitive phenotype [4,9]. Simi-
larly, such chemical-genetic profile analyses can be used
to study cellular target sites of various bioactive com-
pounds [9], pharmaceuticals [10] and herbal extracts
[11] whose mechanisms of action are unknown.
In general, chemical sensitivity profiling of yeast gene
knockouts can be studied using three complementary
high throughput approaches. In the first case, deletion
mutants can be grown individually in liquid cultures
and their growth rates monitored spectrophotometrically
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using a microplate reader. The growth curve of micro-
cultivated mutant strains in the presence and absence of
a bioactive compound is used to determine strain sensi-
tivity [12-14]. The second approach is based on syn-
thetic lethality analysis on microarray (SLAM) [15]. A
pool of tagged deletion strains are grown in the pre-
sence and absence of the target compounds. Owing to
the presence of a specific barcode in each mutant strain,
the relative growth of each strain can be determined
using microarray methodology, and sensitivity is mea-
sured on the basis of the relative growth of a specific
mutant strain in the presence of other strains. The third
approach concerns colonies of yeast gene deletion
mutant strains being arrayed on solid media in the pre-
sence and absence of the target compounds [9,16]. The
growth rates of individual colonies are estimated by
their relative colony size relative to a control. Each of
these techniques has inherent advantages and disadvan-
tages. The results obtained from these methodologies
are considered to be complementary [17].
Recently, we showed that high throughput chemical
sensitivity profile analysis of yeast gene knockout strains
to paromomycin can be used to study novel gene func-
tions, and reported that a previously uncharacterized
open reading frame, TAE1, has a novel role in protein
biosynthesis or translation [18]. In the present study,
colony size reduction was used to screen and analyze
the yeast gene knockout collection for their sensitivity
to five bioactive compounds that target the process of
protein biosynthesis. We followed up by studying the
activities of three profiled genes for their involvements
in protein biosynthesis and termed them TAE2, TAE3
and TAE4 for translation associated elements 2-4.
Results
Drug sensitivity screens
The entire collection of the haploid yeast gene deletion
array (yGDA) (~4700) was screened for increased sensitiv-
ity to the bioactive compounds cycloheximide, 3-amino-
1,2,4-triazole (3-AT), paromomycin, streptomycin and
neomycin. These drugs have reported involvement in pro-
tein biosynthesis or translation. Cycloheximide is a glutari-
mide antibiotic that binds to the 60 S ribosomal subunit
and inhibits translation elongation [19]. 3-AT is a compe-
titive inhibitor of imidazole glycerol phosphate dehydra-
tase, an enzyme involved in the biosynthesis of the amino
acid histidine [20], and causes amino acid starvation [21].
Paromomycin, neomycin and streptomycin are known to
bind the small ribosomal subunit of eukaryotic cells, inhi-
bit ribosomal translocation and compromise translation
fidelity [22]. We hypothesized that sensitivity to these
drugs could be used as a method of identifying new genes
associated with the process of protein biosynthesis. Sub-
inhibitory concentrations of the drugs were used in this
study. Under these growth conditions only strains with
increased sensitivity would demonstrate growth reduction
and the growth of the remaining strains would be largely
unaffected. Each experiment was repeated three times and
the total number of analyses exceeded 70,000. We have
previously reported analysis concerning sensitivity to paro-
momycin [18]. Here, we present the collective analysis of
the total data from the entire collection of sensitive strains.
Colony size (CS) measurement was used to determine
sensitivity. The relative colony growths (normalized to
the average growth on the plate) on treated plates were
compared with those grown under control conditions
(untreated) as described previously [23]. CS measure-
ment is an established method used to identify drug
sensitive strains [9,16,24] and is reported to identify
approximately 63% of sensitive strains detected by stan-
dard large-scale spot test (ST) analysis [23]. Therefore, a
number of sensitive strains that could be detected using
ST analysis may not have been detected using CS, indi-
cating that our approach using CS to identify sensitivity
is not exhaustive. Furthermore, it is reported that 59%
of the sensitive strains detected by CS are not detected
by ST and hence may represent novel/false positives.
To reduce false positive results, gene deletion strains
with sensitivity to different unrelated bioactive com-
pounds that we continuously observed in our previous
independent screens, as well as those reported by others
[25], were eliminated from the list of sensitive strains.
These genes typically represent multiple-drug resistant
genes that are not linked to the cellular target sites of
the drugs of interest. Inclusion of these genes would
complicate the analysis of the molecular activity of the
target compounds. The final list of the genes that when
deleted increased drug sensitivity to the tested bioactive
compounds is presented in Additional file 1. There are
383, 320, 205, 99 and 89 genes that, when deleted, con-
fer increased sensitivity to cycloheximide, 3-AT, strepto-
mycin, neomycin and paromomycin, respectively. These
are non-essential genes that are normally not required
for the growth of yeast cells under typical laboratory
conditions, suggesting that the slow growth phenotype
of the corresponding deletion strains is a direct result of
the inhibitory effects of the target drugs. Cycloheximide,
streptomycin, neomycin and paromomycin bind to ribo-
somes and cause defects in protein synthesis [26,27].
Therefore, as expected, among gene deletion strains
with increased sensitivity to these drugs, we identified
numerous previously characterized protein synthesis
related genes including ribosomal protein L27A gene
YHR010W (RPL27A), translation initiation factor
YJL138C (TIF2), tRNA methyltransferase YDL201W
(TRM8), mitochondrial translation initiation factor
YOL023W (IFM1) and eIF4E-associated gene EAP1
(YKL204W).
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Excluding genes with unknown functions, the cluster-
ing of the identified genes based on the cellular pro-
cesses in which they participate is presented in Figure
1a (also see Additional file 1). The dominant clusters
are protein biosynthesis related genes. For example,
approximately 33% of strains sensitive to cycloheximide
are linked to protein biosynthesis; approximately 24%,
15%, 13%, 5% and 10% are associated with metabolism,
cellular compartments and biogenesis, transport and
stress, DNA repair and replication, and others, respec-
tively. This was expected as cycloheximide, streptomy-
cin, neomycin and paromomycin are known to interact
directly with ribosomal subunits. 3-AT also affects pro-
tein biosynthesis by altering the available pool of amino
acids [20,21].
Smaller clusters could represent additional target sites
(side effects) of the drugs. For example, neomycin is
known to inhibit the phospholipase C pathway and thus
interfere with signal transduction in eukaryotic cells
[28]. This could explain the observation that deletion of
YIL050W (PCL7), which codes for a member of a meta-
bolism-associated Pho85c kinase complex, confers cell
sensitivity to neomycin. The smaller clusters could also
represent novel secondary functions for certain genes,
some of which may link translation to other cellular
processes. For example, deletion of YER095W (RAD51)
or YOL090W (MSH2) increased sensitivity to cyclohexi-
mide. YER095W and YOL090W are involved in repair
of DNA strand breaks. Interestingly, YER095W is
reported to have a genetic interaction (positive genetic)
with the translation termination factor eRF3 gene
YDR172W (SUP35) and the translation elongation factor
YLR249W (YEF3) gene [29], and its product is reported
to interact physically with glutamyl tRNA synthetase
protein, YGL245Wp (Gus1p) [30]. Similarly, the gene
product of YOL090W is reported to interact physically
with the translation initiation factor eIF4A, YJL138C
(TIF2) [31]. This is in agreement with the recently
reported link between DNA damage response and trans-
lation [32]. Alternatively, the smaller clusters could
represent false positive results. However, the most likely
scenario is that each of the aforementioned cases repre-
sents a different integrated part of the data. For exam-
ple, secondary target sites of a drug can be investigated
with the prior knowledge that the smaller clusters could
contain genes with novel secondary functions as well as
a number of false positives. An interesting observation
is that the overall distribution of genes within each
functional cluster was similar for each of the five drugs
investigated herein (Figure 1A). This could represent
cross-talk between protein synthesis and the other four
cellular processes. Based on our previous observations
of chemical-genomic profiles of other inhibitory com-
pounds with diverse modes of action such as calcoflour
white, methyl methane sulfate, and sodium dodecyl sul-
fate, the profiles presented in Figure 1A are distinct
(unpublished data).
As utilized previously [33], a hierarchical clustering
approach to drug sensitivity was used to analyze the
chemical profiles (Figure 1B). It is expected that com-
pounds with similar modes of activity have similar pro-
files with considerable overlaps, and hence cluster
together. As expected, the profiles for paromomycin and
neomycin had considerable overlaps and hence these
compounds were clustered together by hierarchical clus-
tering using complete linkage. These aminoglycosides
bind small ribosomal subunits and compromise transla-
tion fidelity and translocation. Cycloheximide and 3-AT
also had considerable overlaps and were clustered
together as expected; these drugs can affect the elonga-
tion phase of translation. Cycloheximide does so by
binding the 60 S ribosomal subunit [19] whereas 3-AT
causes starvation of amino acids needed for successful
elongation. Interestingly, streptomycin, an aminoglyco-
side, had more overlap and was more closely associated
with cycloheximide and 3-AT. Unlike other aminoglyco-
sides, streptomycin does not bind the ribosomal A-site
[34], implying that streptomycin binding to the ribo-
some could result in an alternative ribosomal conforma-
tion that resembles the action of cycloheximide and 3-
AT. The effect of streptomycin on prokaryotic transla-
tion elongation, which is different from other aminogly-
cosides, is well documented [35].
The overlap of strain sensitivities to different drugs is
represented in Figure 1C. A total of 1519 gene deletion
mutants were identified with increased sensitivity to a
minimum of one drug (Figure 1C); 408 were sensitive to
two or more drugs. A mutant for the vacuole gene
YDR495CΔ (vps3Δ) was sensitive to the five treatments.
This mutant has been observed in other screens, sug-
gesting non-specific involvement in multiple drug resis-
tance. When analyzing the overlapping drug sensitive
strains, the ratio of protein synthesis related genes did
not increase significantly when sensitivities to two or
more drugs were analyzed (Figure 1C and 1D and Addi-
tional file 1). Enrichment in the category of transport
and stress related genes, into which multiple drug resis-
tant genes generally fall, was observed for some multiple
drug sensitive groups. This highlights that selection
based on several drugs could partially target multiple
drug resistant genes.
To investigate the accuracy of our large-scale
approach to detect drug sensitive mutants, five deletion
strains were selected and subjected to spot test analysis
(Figure 2). This analysis confirmed that deletion of
YPL009C confers increased sensitivity to cycloheximide,
deletion of YDR056C increases sensitivity to streptomy-
cin and neomycin, deletion of YJR111C increases
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Figure 1 Clustering of drug sensitive gene deletion mutants. The haploid non-essential yeast gene deletion array was subjected to sub-
inhibitory concentrations of five inhibitory compounds. Colony size reduction was used to detect sensitivity. (A) Drug sensitive yeast gene
deletion mutants were clustered according to the cellular processes in which their deleted genes participated. The overall distributions of gene
functions were comparable for different treatments with protein biosynthesis as a major group for all treatments. (B) Chemical profiles were
clustered according to drug sensitivities to two or more drugs. Hierarchical clustering of mutants is illustrated using complete linkage. Absolute
correlation coefficient (centered) is used for comparability and displayed in Java TreeView. Several regions of interest (a-e) are enlarged. The
cellular processes of the deleted genes are color-coded. On the basis of sensitivity profiles, paromomycin is grouped with neomycin.
Cycloheximide is grouped with 3-AT, which then merges with streptomycin. Sensitivity indexes of the gene deletion mutants are shown as high
to low (light to dark red). (C) Sensitivity overlaps for gene deletion mutants to different drug treatments. The number of gene deletion mutants
with a particular sensitivity, for example paromomycin (P) alone (89), paromomycin and 3-AT (17) and paromomycin, 3-AT and neomycin (3), are
indicated. (D) The overlapping drug sensitive yeast gene deletion mutants are clustered according to the cellular processes in which their
deleted genes participate. No significant enrichment for protein biosynthesis genes among overlapping sensitive strains was observed. The
number of sensitive strains is presented on the z-axis. C: cycloheximide; P: paromomycin; A: 3-AT; N: neomycin; and S: streptomycin. The
sensitivity overlaps between P and N, C and 3-AT, C and S, and 3-AT and S were significant with P-values ≤ 5 × 10-14. Other overlaps are
significant with P-values of ≤ 0.029.
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sensitivity to streptomycin, and deletions of YIL137C
and YPL183W-A increase sensitivity to 3-AT. These
results are in agreement with the large-scale analysis
and confirm that this approach can identify strains that
are sensitive to the drugs used in this study.
Synthetic genetic array (SGA) analysis for TAE2, TAE3 and
TAE4
The majority of mutants with increased sensitivity to the
target drugs had deletions of genes with known func-
tions in protein biosynthesis. Therefore, the activities of
three mutants for genes that are not well characterized,
YPL009C, YIL137C and YPL183W-A, were examined by
studying genetic interactions with previously reported
protein biosynthesis related genes. These genes have not
been characterized but available literature and our
unpublished data suggest possible associations with cer-
tain disease related-genes and phenotypes (see
Discussion).
It is generally accepted that many genes/pathways in
eukaryotic cells are functionally redundant and that
compensation for loss of activity is prevalent [8]. How-
ever, deletion of a second functionally related gene/path-
way could result in sickness or lethality, indicating an
aggravating interaction. Consequently, the sickness of
double mutants can be used to investigate genetic inter-
action and functional relationships between genes (syn-
thetic genetic interaction analysis) [4]. The synthetic
genetic interactions of YPL009C, YIL137C and
YPL183W-A with other protein biosynthesis genes were
investigated by systematically examining double gene
deletions for alterations in colony size [4]. If our tar-
geted genes are involved in protein biosynthesis, it
would be expected on the basis of their molecular func-
tion that they would interact genetically with other
translation genes with related functions. As presented in
Figure 3 and Additional file 2, YPL009C, YIL137C and
YPL183W-A interacted genetically with a number of
Figure 2 Strain sensitivity to different translation-inhibitory drugs. Wild type (WT) or gene deletion mutant strains (yploo9cΔ, yil137cΔ,
ypl183w-aΔ, ydr056cCΔ and yjr111cΔ) were serially diluted to 10-3 to 10-6 and spotted on solid medium with sub-inhibitory concentrations of
cycloheximide, paromomycin, 3-AT, streptomycin and neomycin as indicated, or without drugs (control). The plates were incubated at 30°C for
1-2 days. Deletion of ypl009c confers increased sensitivity to cycloheximide; yil137c and ypl183w-a to 3-AT, ydr056c to streptomycin and
neomycin, and yjr111c to streptomycin.
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translation genes as evidenced by the sick phenotype of
the double mutants. These results suggest a functional
association for our target genes with the process of pro-
tein biosynthesis. Therefore, the studied genes were
named TAE2 (YPL009C), TAE3 (YIL137C) and TAE4
(YPL183W-A), or translation associated elements 2-4,
respectively. The largest group of genes that interacted
with TAE3 and TAE4 were those involved in translation
associated RNA processing, with three and seven inter-
actions, respectively. This group included genes such
RNA exonuclease YLR059C (REX2), which is involved in
rRNA maturation and processing, rRNA binding protein
YHR066Wp (Ssf1p), which is a constituent of the 66 S
pre-ribosomal subunit, and nuclear pore complex pro-
tein YKL068Wp (Nup100p), which is involved in mRNA
and rRNA export and ribosomal protein import to the
nucleus. TAE4 interacted with five genes related to dif-
ferent small ribosomal subunit proteins including
YLR441C, which codes for S1A, and YJL190C, which
codes for S22A. TAE2 had a general pattern of interac-
tion and interacted with genes with differing functions.
The largest groups of genes (three) that interacted with
TAE2 had five members each, with functions in amino
acid biosynthesis, small ribosomal subunit proteins and
regulation of translation.
In addition, some of the identified genetic partners
were shared between the query genes (Figure 3). For
example, YDR025W, which codes for the small riboso-
mal subunit protein S11A, interacted genetically with
TAE2 and TAE4, and YFR009W (GCN20), which is
Figure 3 Synthetic genetic interaction analysis for TAE2, TAE3 and TAE4 with translation related genes. There are 72 interactions that
represent synthetic genetic interactions for three query genes TAE2, TAE3 and TAE4, with 59 different translation genes. Genes are represented as
nodes (circles) and interactions are represented as edges (lines). The interacting genes are further divided into eight functional categories. There
are a number of shared interactions that highlight the interconnectivity of the network. The nodes are coloured according to functional groups.
Black edges represent synthetic sick (aggravating) interactions, and the six pink thick edges represent synthetically rescue (alleviating)
interactions.
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involved in positive activation of GCN2 kinase, inter-
acted with TAE3 and TAE4. Furthermore, a synthetic
genetic interaction between TAE2 and TAE4 was
observed.
In contrast to the aggravating interactions in which
sickness of double mutants was investigated, interactions
concerning double mutants with higher fitness than
expected were examined. Such alleviating interactions,
also known as synthetic rescue, are thought to exist
between genes in the same pathway [36]. Six such inter-
actions were identified in this study (Figure 3). In agree-
ment with the synthetic sickness interactions, which
showed that the largest functional interaction partners
for TAE3 and TAE4 were involved in translation asso-
ciated RNA processing, it was observed that TAE3 inter-
acted with the RNA processing gene YLR107W (REX3)
and with YKL068W (NUP100), a gene involved in RNA
transport from the nucleus and associated with rRNA
and tRNA export, and that TAE4 interacted with
another RNA processing gene, YNL001W (DOM34).
TAE2 had alleviating interactions with three genes with
different functions, namely YKR059W (TIF1), which has
a role in translation initiation, YDR494W (RSM28),
which is involved in mitochondrial translation, and
YDR450W (RPS18A), associated with the structure of
small ribosomal subunits. The diversity of the interac-
tions in which TAE2 is involved mirrors the results of
the synthetic sick interactions, leading to the conclusion
that it did not interact with one major functional group.
A recent genome-wide synthetic genetic interaction
study used TAE3 and TAE4 as query genes and demon-
strated that they formed synthetic sick and lethal inter-
actions predominantly with genes involved in protein
biosynthesis (P-values of 10-7 and 10-16 for TAE3 and
TAE4, respectively) [37], confirming the results pre-
sented herein. Similarly, the synthetic sick and lethal
interactions reported for TAE2 predominantly (P-value
= 0.003) concerned protein biosynthesis genes.
Functional correlations for TAE2 and TAE4 with other
protein synthesis related genes
Overexpression of a gene often compensates for a phe-
notypic consequence caused by the absence of a func-
tionally related gene [38,39]. Therefore, one approach
to studying protein function would be to investigate
whether its overexpression can compensate for the
absence of proteins with known functions. This
approach was used to investigate further the biological
activity of the gene products for TAE2 and TAE4 by
investigating whether their overexpression could
reverse the phenotypic consequences caused by the
absence of other translation genes (phenotypic sup-
pression analysis). For an unknown reason our multi-
ple attempts to isolate an overexpression plasmid for
TAE3 from the yeast gene overexpression library were
unsuccessful. Consequently, TAE3 was omitted from
this part of the investigation. Reduced growth was
used as the target phenotypic consequence for gene
deletion strains cultured in the presence of neomycin
and streptomycin. As indicated in Figure 4 (and Addi-
tional file 3), we observed that the growth defects in
the presence of neomycin and/or streptomycin for a
number of deletion strains for translation genes were
compensated by the overexpression of TAE2 (Figure
4A) or TAE4 (Figure 4B). In agreement with the syn-
thetic genetic interactions described previously, the
two main functional categories that TAE4 overexpres-
sion rescued included genes involved in translation
related RNA processing and 40 S ribosomal structure
maintenance. For example, TAE4 overexpression res-
cued the sensitivity to drugs of deletion strains for the
pre rRNA processing gene YGR159C (NSR1) and the
40 S ribosomal subunit protein S28 gene YGR118W
(RPS23A). These observations can be explained by a
role for TAE4 in 40 S biogenesis, which is in agree-
ment with the synthetic sick and synthetic rescue
interactions observed for TAE4.
As was the case with the synthetic genetic interactions
for TAE2, the phenotypic suppression analysis suggested
a general role for TAE2 in translation. Overexpression
of TAE2 compensated for the deletion of a number of
genes with diverse roles in translation such as
YMR242C (RPL20A), which codes for a 60 S ribosomal
subunit protein, YDR462W (MRPL28), which codes for
a mitochondrial ribosome protein, and YKR059W
(TIF1), which codes for the translation initiation factor
eIF4A.
Three of the rescued gene deletion strains, YDL083CΔ
(rps16BΔ), YPL081WΔ (rps9AΔ) and YIL052CΔ
(rpl34BΔ), were shared between TAE2 and TAE4. This
is in accordance with the synthetic genetic interaction
observed between these two genes (Figure 3). Such
interactions highlight the interconnectivity of a genetic
interaction map for translation genes.
Deletions of TAE2, TAE3 and TAE4 affect the process of
protein synthesis
The genetic interaction analyses provide a direct link
between TAE2, TAE3 and TAE4, and the process of pro-
tein biosynthesis. To investigate this link further we
examined the effect of deletion of the target genes on
translation efficiency, stop codon readthrough and ribo-
some biogenesis. If any differences were detected we
would expect them to be subtle owing to the impor-
tance of protein biosynthesis for cell survival and the
fact that the deletion of the target genes does not
change the growth rate of the mutants under standard
laboratory conditions.
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We first investigated the involvement of TAE2 ,
TAE3 and TAE4 in translation efficiency. Deletion
mutants tae2Δ, tae3Δ and tae4Δ were subjected to
[35S] methionine incorporation analysis. tae2Δ, tae3Δ
and tae4Δ mutant strains demonstrated approxi-
mately 30%, 14% and 10% reduced levels of [35S]
methionine incorporation, respectively (Figure 5A).
To complement these findings, we investigated the
rate of protein synthesis using an inducible b-galacto-
sidase reporter construct (p416) under the control of
a GAL1 promoter [40], which better highlights differ-
ences in translation efficiencies [18]. After four hours
of induction, levels of b-galactosidase activity were
six fold lower for tae2Δ and tae3Δ mutants, and five
fold lower for tae4Δ (Figure 5B) while their mRNA
contents remained relatively unchanged (data not
shown).
A plasmid-based b-galactosidase system with different
premature termination codons was used to study stop
codon readthrough. In this approach alterations in
translation fidelity lead to an increase in termination
codon readthrough and thus elevate the production of
full length functional b-galactosidase. To this end, target
deletion strains were transformed with three different
plasmids, pUKC815, pUKC817and pUKC818 [41], and
the expression of b-galactosidase in each mutant was
quantified. pUKC815 contains no in-frame premature
termination codon and was used as a control. pUKC817
and pUKC818 contain in-frame termination codons
UAA and UAG, respectively. Apparent from the
increased relative productions of b-galactosidase shown
in Figure 5C, deletion of TAE2, TAE3 and TAE4
resulted in higher levels of termination codon read-
through. Comparable levels of b-galactosidase mRNA
were evident in each of the tested strains (data not
shown) demonstrating that the observed increase s in b-
galactosidase activity were not due to altered levels of
mRNA.
Figure 4 Overexpression of TAE2 and TAE4 suppresses the sensitivity of numerous translation genes to drug treatments.
Overexpression of TAE2 and TAE4 suppresses the phenotype of a number of translation gene deletion strains against neomycin and/or
streptomycin treatments. Genes are represented as nodes (circles) and interactions are represented as edges (lines). The interacting genes are
divided into functional categories and colored accordingly. (A) TAE2 over-expression rescued 20 gene deletions with a variety of functions. (B)
TAE4 over-expression rescued 18 gene deletions, the majority of which are 40 S subunit proteins (nine genes) or function as translation-
associated RNA processing proteins (five genes). Blue letters represent genes that are rescued by the overexpression of both TAE2 and TAE4.
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A surprising observation was that deletion of TAE4
resulted in a higher readthrough for the UAA
(pUKC817) stop codon but not UAG (pUKC818). Gen-
erally, it is expected that alterations in translation fide-
lity result in more readthrough for a less stringent stop
codon, in this case UAG. This was observed for tae2Δ
and tae3Δ but not tae4Δ. A possible explanation is that
deletion of TAE4 causes an alteration that is stop codon
specific. For example, it could reduce the affinity of
ribosomes for a specific translation release factor (RF)
but not others.
Next, the ribosome profiles for tae2Δ, tae3Δ and
tae4Δ gene deletion strains were investigated. The
profiles had three peaks associated with free 40 S and
60 S subunits and 80 S monosomes, followed by a series
of peaks representing polysomes (Figure 5D). The ribo-
some profile for tae2Δ was comparable to the wild type
strain (data not shown). However, for tae3Δ, a reduction
in polysomes was observed, as was an increase in free
60 S subunit (Figure 5D). The free 60S:40 S subunit
ratio for this mutant was 2.94 ± 0.51 in comparison to
1.77 ± 0.29 for the wild type. Similarly, the profile for
tae4Δ demonstrated a significant increase in free 60 S
subunits, a slight increase in 80 S monosomes and a
slight reduction in larger polysomes (Figure 5D). The
free 60S:40 S subunit ratio for tae4Δ was 5.34 ± 0.71.
Figure 5 Characterization of TAE2, TAE3 and TAE4 deletions. (A) Total protein synthesis was measured using [35S] methionine incorporation
in wild type, tae2Δ, tae3Δ and tae4Δ strains. The average count for [35S] methionine incorporation for wild type was 11,356,073 (± 1,400,000)
counts, which is set to 100%. On average, in the absence of Tae2p, Tae3p and Tae4p, [35S] methionine incorporation was reduced by
approximately 30, 14 and 10%, respectively. (B) The efficiency of protein synthesis was measured using an inducible b-galactosidase reporter
construct (p416). The average b-galactosidase activity for wild type was 7.5 (± 0.6) units, which is set to 100%. The b-galactosidase activity was
measured after 4 h induction. Deletion of TAE2, TAE3 and TAE4 limited the expression of b-galactosidase to 13, 21 and 17% of that in wild type,
respectively. (C) Deletion of TAE2, TAE3 and TAE4 resulted in increased levels of b-galactosidase from lacZ reporters with different premature stop
codons (pUKC817 and pUKC818). The activity of b-galactosidase was determined by normalizing the activity of the mutant (pUKC817 and
pUKC818) to the control (pUKC815). pUKC815 is the background construct without a premature stop codon and is used as a control. Bars
represent standard deviations for the means. (D) Ribosome profile analysis of yeast deletion strains tae3Δ and tae4Δ compared to wild type.
Deletion of TAE3 decreased the levels of polysomes and increased free 60 S subunits. Deletion of TAE4 caused an increase in free 60 S subunits
and a slight decrease in larger polysomes. Each experiment was repeated a minimum of three times. Ratios of free 60S:40 S were calculated
from the areas under the curves.
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Reduction of polysomes could explain the observed
reductions in the efficiency of protein synthesis for
tae3Δ and tae4Δ. Alterations in the pool of free riboso-
mal subunits could relate to deficits in subunit biogen-
esis, suggesting that TAE3 and TAE4 could be involved
in the process of ribosome biogenesis. The 40 S and 60
S subunits are in equilibrium with 80 S monosomes,
therefore an increase in 60 S free subunits could relate
to a defect in 40 S biogenesis [42] as observed for tae3Δ
and tae4Δ mutants. A more precise calculation for mea-
suring free 60S:40 S involves measuring 40 S and 60 S
subunits separated on a sucrose gradient with low con-
centrations of Mg2+, but this was not carried out in the
present study.
Discussion
Gene deletions that cause increased sensitivity to a
bioactive compound can be used to identify pathways
that buffer the cell against the activity of that compound
[43]. Therefore, chemical-genetic profiles of inhibitory
compounds can lead to identification of their overall
mode of action and any side effects associated with toxi-
city of the drug. Furthermore, these profiles can help
identify novel genes involved in specific cellular path-
ways targeted by compounds [9]. In this study the sensi-
tivity of a yeast gene deletion array to five different
bioactive compounds was investigated using colony size
reduction as the endpoint. The overall profiles of these
compounds were comparable, with the deletion of genes
involved in protein biosynthesis being the dominant
cluster. Further investigations concerned three sensitive
deletion strains for genes that are not well characterized,
that here we term TAE2, TAE3 and TAE4. Genetic ana-
lyses provided evidence for involvement of these genes
in protein biosynthesis.
There is limited information relating to the molecular
activity of Tae4p. In a large-scale investigation it was
reported that deletion of TAE4 rescued the temperature
sensitivity of cdc13-1, so it was thought to be a restrictor
of telomere capping; Cdc13p is an essential protein
involved in checkpoint and telomere capping. The C-
terminal domain of Tae4p, amino acids 56-93, has
sequence homology to the prokaryotic ribosomal protein
L36. In the current study it was observed that TAE4
formed synthetic sick interactions with two predominant
categories of genes with functions in RNA processing
associated with protein biosynthesis and genes that code
for 40 S ribosomal subunit associated proteins. Further-
more, it formed phenotypic suppression interactions
with the same two categories of genes, linking the activ-
ity of TAE4 to RNA processing and the 40 S subunit.
TAE4 involvement in 40 S biogenesis was confirmed by
ribosome profile analysis and explains the observed
effects of the deletion of TAE4 on stop codon
readthrough and the efficiency of translation. Further-
more, TAE4 is co-regulated with several rRNA proces-
sing proteins such as the LSM protein YJR022Wp
(Lsm8p) implicated in pre-rRNA and pre-tRNA proces-
sing [44] and a preribosome processing protein
YLR409Cp (Utp21p) involved in 18 S rRNA processing
[45]. These observations, together with the results pre-
sented here, provide strong evidence that the activity of
TAE4 is related to RNA processing and ribosome bio-
genesis. The C-terminal domain of Tae4p contains two
RNA binding domains. Therefore, Tae4p can affect
rRNA processing by directly binding to rRNA or by
recruiting other factors to rRNA, which in turn can
affect ribosome biogenesis.
TAE2 (YPL009C) has no previously reported cellular
function but its protein product shares a domain similar
to the human colon cancer antigen 1 (SDCCAG1) and
has some sequence homology with a putative RNA
binding protein in Drosophila melanogaster. The syn-
thetic sick and synthetic rescue genetic interaction ana-
lyses presented herein indicated a diverse interaction
pattern for TAE2 with various translation genes. TAE2
overexpression rescued the phenotype of deletion strains
for genes with different functions in various steps of
translation, suggesting a general involvement of TAE2 in
protein biosynthesis that is not targeted to a specific
pathway. Deletion of TAE2 caused an increase in stop
codon readthrough and a decrease in translation effi-
ciency. One possible explanation for these results is that
TAE2 could transiently aid in mediating the overall
activity of ribosomes and hence translation efficiency
and fidelity. Translation in vivo is more efficient than in
reconstituted in vitro experiments, indicating the pre-
sence of uncharacterized translation elements in vivo
[46]. The activity of TAE2 is supported by the observa-
tion that in large-scale affinity purification experiments
Tae2p co-purified with several ribosomal subunit pro-
teins [30]. However, low concentrations of salt destabi-
lize this interaction [47] suggesting that Tae2p
transiently interacts with ribosomes. In addition, Tae2p
was recently computationally predicted to interact
directly with the ribosomal subunit protein YDR418Wp
(Rpl2Bp) [48].
TAE3 predominantly formed synthetic sick interac-
tions with RNA processing genes involved in translation
and formed synthetic rescue interactions with genes
with similar RNA processing functions. Alterations in
the ribosomal profile of the tae3Δ strain suggest a defi-
ciency in 40 S subunit biogenesis, and a role for TAE3
in RNA processing associated with 40 S biogenesis
could explain these observations. In addition, this would
explain the observation that deletion of TAE3 caused an
increased stop codon readthrough and a reduction in
the efficiency of protein synthesis. In agreement with
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this role for TAE3, the expression of TAE3 is reported
to be strongly co-regulated with essential translation
genes including YAL003W (FUN53), which codes for a
subunit of RNase MRP involved in pre-rRNA cleavage,
and YBL004W (UTP20), which is involved in 18 S rRNA
processing [49]. Tae3p does not appear to contain an
RNA binding domain. Therefore, it is possible that
Tae3p may interact with an intermediate RNA binding
protein(s) in order to exert its activity. In agreement
with this, Tae3p was reported to co-purify with
YOR272Wp (Ytm1p), a constituent of the 66 S pre-ribo-
somal particle [50]. In addition, we previously observed
that deletion of TAE3 reduced the efficiency of double
stranded DNA break repair, which could be an indepen-
dent activity for TAE3 (unpublished data).
The effect of TAE3 deletion on stop codon read-
through is in agreement with a previous study [47].
However, the same investigation detected no apparent
alteration in translation efficiency. A possible explana-
tion for this difference is that the latter study utilized
diploid homozygous gene deletion cells whereas the cur-
rent study used haploid cells and the efficiency of
induced translation was not measured in the former.
Differences between the experimental observations in
the haploid and diploid systems have been reported [51].
Conclusion
The overall chemical-genetic profiles of the investigated
compounds were comparable, with genes associated
with protein biosynthesis being the dominant cluster,
followed in a broad descending order by those involved
in metabolism, cellular compartments and biogenesis,
transport and stress, DNA repair and replication, and
others. This observation may further underline pre-
viously speculated links between protein biosynthesis
and other fundamental cellular processes. The smaller
clusters could also represent alternative modes of activ-
ities for these compounds. Genetic investigations of
three profiled genes further highlighted the effectiveness
of chemical-genetic profiling for the investigation of
gene functions for translation genes.
Methods
Growth media
Standard rich (YPD) and synthetic complete (SC) media
were used for the experiments [52]. Yeast cells were
grown at 30°C for 1-2 days. The YPD medium contain-
ing Geneticin (G418; 200 μg/ml) was used for the main-
tenance of deletion strains carrying the G418r marker.
To investigate the effects of drugs on the growth of
yeast deletion mutants, paromomycin (10 mg/ml), strep-
tomycin (40 mg/ml), neomycin (5.5 mg/ml) and 3-AT
(22 mg/ml) were added to SC medium and cyclohexi-
mide (45 ng/ml) was added to YPD medium. G418
sulfate, cycloheximide and 3-AT were purchased from
Sigma and paromomycin sulfate from Fluka. Neomycin
sulfate and streptomycin were obtained from Bioshop,
Canada.
Drug sensitivity analysis
MIC for each compound was measured as the lowest
drug concentration that resulted in inhibition of visible
growth of yeast strains on sterile 96-well microtitre
plates. A standard protocol was used [53]. Serial dilu-
tions of the compounds were added to the test microti-
tre plates. Plates were incubated at 30°C for 1-2 days.
Inhibition of growth was visually compared with control
wells containing no drugs.
For high throughput phenotypic screenings, approxi-
mately 4700 MATa haploid gene deletion strains of S.
cerevisiae in the BY4742 (MATa ura3Δ0 leu2Δ0 his3Δ1
met15Δ0) parental strain were maintained in an ordered
array of approximately 384 individual strains in 16
plates. Gene deletion mutants were arrayed using a
BioRAD colony arrayer robot or a V&P hand-held
arrayer on to agar plates with sub-inhibitory concentra-
tions of 3-AT (22 mg/ml), paromomycin (10 mg/ml),
cycloheximide (45 ng/ml), streptomycin (40 mg/ml) and
neomycin (5.5 mg/ml) or without drugs (control) in a
method similar to that described by Parsons et al. [9]
and as previously described [11]. After 1-2 days incuba-
tion at 30°C, digital images of the plates were captured
and analyzed as previously described [23] with some
modifications. In brief, images were converted to black
(media) and white (colonies) and segmented using
threshold values derived from Otsu’s approach [54].
Objects empirically determined to be smaller than
0.00025 of the total white pixels in a plate were consid-
ered artifacts and eliminated. Colonies were ordered on
the basis of local centers and area maps. The average
value of white pixels Save (average colony size) for each
plate Pn was calculated from equation (1) where N was
the total number of colonies and S i was the area of
object i in plate Pn.
S N Save Pn i Pn
i
N
  = =∑1 1/ (1)
The relative size of each colony was calculated by sub-
tracting the Save Pn from the ordered array area
explained in equation (2) for each plate.
ΔS S S ii i ave Pn= − = ; , ,1 384 (2)
The relative size of colonies calculated in this way was
used to determine relative growth differences for each
colony under different experimental conditions (that is,
treated versus control); each experiment was repeated
three times. Colonies that demonstrated 30% or more
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reduction in two replicates, or those with an average
reduction of more than 20% (with internal variation of
20% or less) in all three experiments, were classified as
“hits” or sensitive colonies.
Sensitivities of selected mutant strains identified in
primary screens were confirmed by spot test analysis.
Yeast cells were grown in YPD or SC liquid media to
mid-log phase and diluted to a concentration of 10-3 to
10-6 cells/20 μl. From each dilution, 20 μl was spotted
on to medium containing sub-inhibitory concentrations
of the drugs or without drugs (control). The growth pat-
terns were compared after 1-2 days at 30°C as described
by Jessulat et al. [55]. Each experiment was repeated a
minimum of three times.
High throughput synthetic genetic interaction and
phenotypic suppression analysis
Gene deletions in the Mata (Y7092) strain were gen-
erated by PCR-based gene targeting [56]. The 5’- and
3’-flanking regions of the target gene (55 bp for either
end) and nourseothricin (NAT) resistance marker [57]
were amplified. The PCR product was directly used to
transform yeast cells. Transformants were selected on
YPD medium containing 150 μg/ml NAT. Proper
integration of the deletion cassette was confirmed by
PCR.
Synthetic genetic array analyses were carried out as
described previously [4]. Briefly, each query strain car-
rying a target gene deletion in a MATa background
was crossed with a set of 384 yeast deletion mutants
(MATa) known to be involved in translation. Diploids
were sporulated and the resulting haploids were
grown on selective plates. After several selection steps,
MATa haploids carrying double gene mutations were
selected. The sickness of double gene mutants was
evaluated by comparing their relative quantified
growth (colony size) with those for single gene mutant
strains using GD software [23]. For synthetic sickness,
growth differences of 30% or more were selected as
positive. For alleviating interactions, growth differ-
ences of 20% or more were selected. The identified
synthetic genetic interactions were confirmed by ran-
dom spore analysis [58].
Gene overexpression constructs are described by
Sopku et al. [59]. Suppression analysis was performed as
before [18]. Briefly, overexpression plasmids were trans-
formed into a MATa strain. The transformed strains
were crossed with a set of yeast gene deletion strains for
384 translation genes as above. The sensitivities of yeast
strains containing the overexpression constructs were
compared to those with a control plasmid or no plas-
mid, against neomycin and streptomycin, using colony
size measurements. A cut off value of 30% or more was
used.
Genetic assays
Alterations in translation fidelity were measured using
plasmids pUKC817 and pUKC818, which carry the pre-
mature stop mutations UAA and UGA, respectively, in
a b-galactosidase expression cassette. pUKC815 contains
no premature stop codon and was used as a control.
b-galactosidase was assayed using O-nitrophenyl-a-D-
galactopyranoside (ONPG) as described previously [60]
with some modification. Briefly, mutant cells were
grown overnight in minimal media. Subcultures were
grown to the exponential phase (OD600 ~1.0), cells were
collected by centrifugation and were resuspended in Z-
buffer. The units of enzyme activity were calculated as
nanomoles and represent the level of ONPG hydrolyzed
per microgram of total protein [61]. All assays were
conducted in triplicate. Real-time PCR analysis was per-
formed using Rotor Gene RG-300 from Corbett
Research as described [18]. Yeast total RNA was isolated
using a Bio-Rad total RNA extraction kit. The total
RNA was quantified by monitoring absorbance at 260
nm. cDNA was synthesized using 0.5 μg of total
extracted RNA from each of the strains using reverse
transcriptase (Bio-Rad) according to the manufacturer’s
instructions at 42°C for 45 min, and the reaction was
stopped by 5 min incubation at 85°C.
The rate of total protein synthesis was evaluated in vivo
by measuring the incorporation of [35S] methionine into
the cellular proteins as previously described by Schwartz
and Parker [62] with modifications. Briefly, yeast strains
were grown to mid-log phase at 30°C in YPD. The cells
were harvested, resuspended in pre-warmed minimal
medium lacking methionine, and supplemented with 10
μCi/ml of [35S] methionine. The cells were incubated for
1 h at 30°C and harvested by centrifugation. The samples
were washed with distilled water six times and 2 μl ali-
quots were collected on Whatman paper. The paper was
air dried and exposed to storage phosphor screen for 1 h.
The amount of radioactivity incorporated into total cellu-
lar proteins was measured by a Cyclon storage phosphor
screen reader. Each experiment was repeated at least five
times. Induced translation was measured using an induci-
ble b-galactosidase reporter gene in p416 [41] plasmid
after 4 h induction.
Polysome preparations were obtained according to the
protocol of Foiani et al. [63]. Haploid yeast mutant and
wild type strains were grown on YPD at 30°C to an
OD600 of 0.8-1.0, and to a density of 2 × 10
7 cells/ml.
Immediately, 200 μl of cycloheximide (50 μg/ml) was
added, and each culture was quickly chilled in an ice
water bath. Cells were harvested, washed and centri-
fuged at 4000 rpm for 4 min at 4°C using a Sorvall
SLA-1500 rotor to separate the supernatant. Cell pellets
were resuspended in 10 ml of ice-cold breaking buffer A
(YA buffer: 10 mM Tris-HCl [pH 7.4], 100 mM NaCl,
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30 mM MgCl2, cycloheximide 50 μg/ml, heparin 200
μg/ml) and centrifuged at 4000 rpm for 4 min at 4°C
(Sorvall SS34 rotor) twice. Pellets were resuspended in
0.5 ml of YA buffer, lysed by vortexing with glass beads
and stored at -80°C. Twenty OD260 units of each super-
natant were fractionated on 8-48% sucrose gradients
containing 50 mM Tris-acetate (pH 7.0), 50 mM
NH4Cl, 12 mM MgCl2, and 1 mM dithiothreitol. The
extract was centrifuged for 2.5 h at 39,000 rpm using a
SW40-Ti rotor in a Beckman LE-80 K at 4°C. The poly-
some profiles were analyzed by monitoring the absor-
bance at 254 nm in a Beckman spectrophotometer.
Additional material
Additional file 1: Gene deletion sensitivities to different bioactive
compounds.
Additional file 2: Descriptions of translation related genes that
interact genetically with TAE2, TAE3 and TAE4 and produce a
synthetic sick phenotype.
Additional file 3: Descriptions of translation related genes that are
phenotypically suppressed by overexpression of TAE2 and TAE4
against treatment with neomycin and/or streptomycin.
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